Literature DB >> 20023687

Warfarin: safe in dialysis patients with atrial fibrillation?

Robert R Quinn, Nairne Scott-Douglas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20023687     DOI： 10.1038/nrneph.2009.212

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  10 in total

1.  Incidence of stroke among chronic hemodialysis patients with nonrheumatic atrial fibrillation.

Authors:  M Wiesholzer; F Harm; G Tomasec; G Barbieri; D Putz; P Balcke
Journal:  Am J Nephrol       Date:  2001 Jan-Feb       Impact factor: 3.754

2.  Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis.

Authors:  E Vázquez; C Sánchez-Perales; F Borrego; M J Garcia-Cortés; C Lozano; M Guzmán; J M Gil; M J Borrego; V Pérez
Journal:  Am Heart J       Date:  2000-12       Impact factor: 4.749

3.  [ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--excutive summary].

Authors:  Valentin Fuster; Lars E Rydén; David S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; Jean-Yves Le Heuzey; G Neal Kay; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; Samuel Wann; Silvia G Priori; Jean-Jacques Blanc; Andrzej Budaj; A John Camm; Veronica Dean; Jaap W Deckers; Catherine Despres; Kenneth Dickstein; John Lekakis; Keith McGregor; Marco Metra; João Morais; Ady Osterspey; José Luis Zamorano; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffery L Anderson; Elliott M Antman; Sharon Ann Hunt; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Rev Port Cardiol       Date:  2007-04       Impact factor: 1.374

4.  Anticoagulant and antiplatelet usage associates with mortality among hemodialysis patients.

Authors:  Kevin E Chan; J Michael Lazarus; Ravi Thadhani; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2009-03-18       Impact factor: 10.121

5.  Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis.

Authors:  Carl van Walraven; Robert G Hart; Daniel E Singer; Andreas Laupacis; Stuart Connolly; Palle Petersen; Peter J Koudstaal; Yuchiao Chang; Beppie Hellemons
Journal:  JAMA       Date:  2002-11-20       Impact factor: 56.272

6.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

7.  Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.

Authors:  Kevin E Chan; J Michael Lazarus; Ravi Thadhani; Raymond M Hakim
Journal:  J Am Soc Nephrol       Date:  2009-08-27       Impact factor: 10.121

8.  VKORC1 haplotypes are associated with arterial vascular diseases (stroke, coronary heart disease, and aortic dissection).

Authors:  Yibo Wang; Weili Zhang; Yuhui Zhang; Yuejin Yang; Lizhong Sun; Shengshou Hu; Jilin Chen; Channa Zhang; Yi Zheng; Yisong Zhen; Kai Sun; Chunyan Fu; Tao Yang; Jianwei Wang; Jing Sun; Haiying Wu; Wayne C Glasgow; Rutai Hui
Journal:  Circulation       Date:  2006-03-20       Impact factor: 29.690

Review 9.  Warfarin anticoagulation in hemodialysis patients: a systematic review of bleeding rates.

Authors:  Meghan J Elliott; Deborah Zimmerman; Rachel M Holden
Journal:  Am J Kidney Dis       Date:  2007-09       Impact factor: 8.860

10.  Atrial fibrillation in chronic dialysis patients in the United States: risk factors for hospitalization and mortality.

Authors:  Kevin C Abbott; Fernando C Trespalacios; Allen J Taylor; Lawrence Y Agodoa
Journal:  BMC Nephrol       Date:  2003-01-24       Impact factor: 2.388
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.